LanzaTech Q2 2026 financial results
- Operating expenses fell to $11.7m in Q2 2026, a 67% improvement versus $35.1m a year earlier.
- Reported net income of $184.3m in Q2 2026, driven primarily by a large non-cash unrealized gain on its SGLT investment.
- Selected North Sea Port, Ghent for the FLITE Alcohol-to-Jet SAF facility targeting 79,000 tpa SAF and 9,000 tpa renewable diesel, with ~ $115m estimated annualized offtake revenue.
- SGLT IPO on the Hong Kong Stock Exchange raised ~US$75m for the JV; LanzaTech retained ~8.38% (33,520,231 H shares) with an estimated market value of ~$110m as of Aug 12, 2026.
Financial performance
For the quarter ended June 30, 2026, revenue was $9.0 million (down 1% year-over-year). Operating expenses improved to $11.7 million, a 67% reduction versus Q2 2025. Adjusted EBITDA loss narrowed to $(7.6) million, an approximate 74% improvement versus $(29.7) million. Reported net income was $184.3 million, primarily reflecting a significant non-cash unrealized gain on the Company’s investment in SGLT. For the six months ended June 30, 2026, net income was $169.6 million, driven largely by a $208.1 million unrealized gain; adjusted EBITDA loss decreased to $15.5 million versus $60.2 million a year earlier.
Project and certification progress
In May, LanzaTech selected North Sea Port, Ghent, Belgium as the permanent site for the FLITE commercial-scale Alcohol-to-Jet facility, targeting 79,000 tonnes of SAF and 9,000 tonnes of renewable diesel annually and estimating roughly $115 million in potential annualized offtaking revenues. The company is also pursuing the world’s first ISCC EU certification pathway for recycled carbon fuels in China to enable access to RED III–compliant and UK Department for Transport–recognized markets.
Strategic moves and partnerships
LanzaTech was added to the Russell 3000 and Russell 2000 indexes effective June 29, 2026. In June, the Beijing Shougang LanzaTech joint venture (SGLT) completed an IPO on the Hong Kong Stock Exchange, raising about US$75 million for SGLT; LanzaTech retained 33,520,231 H shares (~8.38%) with an estimated market value near $110 million as of Aug 12, 2026. The company also launched a multi-year collaboration with BRIGHT at DTU to develop a next-generation C1 biofoundry.
Source: LanzaTech
